Sequential Chemotherapy Followed by Radiotherapy Versus Concurrent Chemo-Radiation in Muscle Invasive Bladder Cancer
Urology Journal,
Vol. 20 (2023),
25 December 2022
https://doi.org/10.22037/uj.v20i.7525
Abstract
Bladder cancer is diagnosed at older age compared to all other known cancer types. Radical cystectomy after neoadjuvant chemotherapy or tri-modality treatment (consist of TURB, concurrent chemo-radiation) are the standard treatments. Many of the patients cannot receive tri-modality treatment (concurrent chemo-radiation) because of medical comorbidities. The present study assessed the results of sequential use of chemotherapy and radiotherapy versus concurrent use of them in 266 muscle invasive bladder cancer patients. The results showed similar overall survival but lower disease-free survival in the sequential group. Recurrence rate was higher in the concurrent group. The results showed that sequential use of chemotherapy and radiotherapy provides comparable results to concurrent use of them and provides better results than less than tri-modality treatments.
- bladder
- cancer
- radiotherapy
- chemotherapy
- sequential
How to Cite
References
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209-49.
Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7-33.
Lobo N, Mount C, Omar K, Nair R, Thurairaja R, Khan MS. Landmarks in the treatment of muscle-invasive bladder cancer. Nature Reviews Urology. 2017;14:565-74.
www.NCCN.org
James ND, Hussain SA, Hall E, Jenkins P, Tremlett J, Rawlings C, et al. Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer. New England Journal of Medicine. 2012;366:1477-88.
Kimura T, Ishikawa H, Kojima T, Kandori S, Kawahara T, Sekino Y, et al. Bladder preservation therapy for muscle invasive bladder cancer: the past, present and future. Japanese Journal of Clinical Oncology. 2020;50:1097-107.
Verschoor N, Heemsbergen WD, Boormans JL, Franckena M. Bladder-sparing (chemo) radiotherapy in elderly patients with muscle-invasive bladder cancer: a retrospective cohort study. Acta Oncologica. 2022;61:1019-25.
www.uptodate.com
Izumi K, Iwamoto H, Yaegashi H, Shigehara K, Nohara T, Kadono Y, et al. Gemcitabine plus cisplatin split versus gemcitabine plus carboplatin for advanced urothelial cancer with cisplatin-unfit renal function. in vivo. 2019;33:167-72.
International Collaboration of T, Medical Research Council Advanced Bladder Cancer Working P, European Organisation for R, Treatment of Cancer Genito-Urinary Tract Cancer G, Australian Bladder Cancer Study G, National Cancer Institute of Canada Clinical Trials G, et al. International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial. J Clin Oncol. 2011;29:2171-7.
Korpics MC, Block AM, Martin B, Hentz C, Gaynor ER, Henry E, et al. Concurrent chemotherapy is associated with improved survival in elderly patients with bladder cancer undergoing radiotherapy. Cancer. 2017;123(18):3524-31.
Jiang DM, Chung P, Kulkarni GS, Sridhar SS. Trimodality Therapy for Muscle-Invasive Bladder Cancer: Recent Advances and Unanswered Questions. Curr Oncol Rep. 2020;22:14.
Mottet N, Ribal MJ, Boyle H, De Santis M, Caillet P, Choudhury A, et al. Management of bladder cancer in older patients: Position paper of a SIOG Task Force. Journal of geriatric oncology. 2020;11:1043-53.
Verschoor N, Heemsbergen WD, Boormans JL, Franckena M. Bladder-sparing (chemo)radiotherapy in elderly patients with muscle-invasive bladder cancer: a retrospective cohort study. Acta Oncol. 2022;61:1019-25.
Huang S, Tseng W-H, Liu C-L, Kuo J-R, Hun S-H, Chen C-H, et al. Comparison of trimodal therapy versus radical cystectomy for each stage of muscle-invasive bladder cancer. Urological Science. 2021;32.
Tholomier C, Souhami L, Kassouf W. Bladder-sparing protocols in the treatment of muscle-invasive bladder cancer. Translational andrology and urology. 2020;9:2920.
Nishihara K, Ueda K, Kurose H, Ogasawara N, Hiroshige T, Chikui K, et al. Survival outcomes of non-definitive therapy for muscle-invasive bladder cancer. Oncol Lett. 2022;23:126.
Majewski W, Nieckula J, Dworzecki T, Miszczyk L. Bladder-conserving Approach in Radical Treatment of Patients With Bladder Cancer–A Single-institution Experience. Anticancer Research. 2020;40:5861-8.
Mottet N, Ribal MJ, Boyle H, De Santis M, Caillet P, Choudhury A, et al. Management of bladder cancer in older patients: Position paper of a SIOG Task Force. Journal of geriatric oncology. 2020;11:1043-53.
D’Andrea D, Soria F, Zehetmayer S, Stangl-Kremser J, Grubmüller B, Abufaraj M, et al. Comparative effectiveness of radical cystectomy and radiotherapy without chemotherapy in frail patients with bladder cancer. Scandinavian Journal of Urology. 2020;54:52-7.
Gergelis KR, Kreofsky CR, Choo CS, Viehman J, Harmsen WS, Lester SC, et al. Outcomes and Profiles of Older Patients Receiving Definitive Radiation Therapy for Muscle-Invasive Bladder Cancer at a Tertiary Medical Center. Practical Radiation Oncology. 2020;10:e378-e87.
Hammer L, Laufer M, Dotan Z, Leibowitz-Amit R, Berger R, Felder S, et al. Accelerated hypofractionated radiation therapy for elderly frail bladder cancer patients unfit for surgery or chemotherapy. American Journal of Clinical Oncology. 2019;42:179-83.
Symon N, Mattout J, Lewin R, Hammer L, Laufer M, Berger R, et al. Is Ultra Hypofractionated Radiation Therapy a Safe and Effective Treatment for Invasive Bladder Cancer in the Elderly?: A Retrospective Single Institution Review. American Journal of Clinical Oncology. 2021;44:369-73.
Lavery HJ, Stensland KD, Niegisch G, Albers P, Droller MJ. Pathological T0 following radical cystectomy with or without neoadjuvant chemotherapy: a useful surrogate. The Journal of urology. 2014;191:898-906.
Robins D, Matulay J, Lipsky M, Meyer A, Ghandour R, DeCastro G, et al. Outcomes following clinical complete response to neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma of the bladder in patients refusing radical cystectomy. Urology. 2018;111:116-21.
Milosevic M, Gospodarowicz M, Zietman A, Abbas F, Haustermans K, Moonen L, et al. Radiotherapy for bladder cancer. Urology. 2007;69:80-92.
- Abstract Viewed: 31 times
- Just Accepted-7525 Downloaded: 19 times